drugset / Trial / NCT04898387
Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.
RandomizedParallel-groupSingle-blindTreatment
Summary
To demonstrate the non-inferiority of T4030 unpreserved eye drops compared to Ganfort® UD in terms of efficacy.
Timeline
- Start
- 2021-03-26
- Primary completion
- 2023-04-13
- Completion
- 2023-05-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bimatoprost | Other / unclassified | — | Other |
| Subject | Timolol | Other / unclassified | — | Other |